T1	Disorder 10 47	Primary ovarian large B-cell lymphoma
T2	Disorder 64 93	juvenile rheumatoid arthritis
N1 	Reference T2 UMLS:C3495559	juvenile rheumatoid arthritis
N2 	Reference T2 UMLS:C3714757	juvenile rheumatoid arthritis
T3	Pharmacological_substance 116 128	Methotrexate
N1000 	Reference T3 MeSH:D008727	Methotrexate
T4	Disorder 151 167	ovarian lymphoma
T5	Disorder 184 196	rare disease
N3 	Reference T5 UMLS:C0012634	rare disease
T6	Disorder 299 319	rheumatoid arthritis
N4 	Reference T6 UMLS:C0003873	rheumatoid arthritis
T7	Disorder 321 323	RA
N5 	Reference T7 UMLS:C0003873	RA
T8	Disorder 399 421	non-Hodgkin's lymphoma
N6 	Reference T8 UMLS:C0024305	non-Hodgkin's lymphoma
T9	Disorder 423 426	NHL
N7 	Reference T9 UMLS:C0024305	NHL
T10	Disorder 505 534	juvenile rheumatoid arthritis
N8 	Reference T10 UMLS:C3495559	juvenile rheumatoid arthritis
N9 	Reference T10 UMLS:C3714757	juvenile rheumatoid arthritis
T11	Disorder 536 539	JRA
N10 	Reference T11 UMLS:C3495559	JRA
N11 	Reference T11 UMLS:C3714757	JRA
T12	Pharmacological_substance 554 566	Methotrexate
N1001 	Reference T12 MeSH:D008727	Methotrexate
T13	Pharmacological_substance 568 571	MTX
N1002 	Reference T13 MeSH:D008727	MTX
T14	Disorder 577 595	malignant lymphoma
N12 	Reference T14 UMLS:C0024299	malignant lymphoma
T15	Disorder 692 714	non-Hodgkin's lymphoma
N13 	Reference T15 UMLS:C0024305	non-Hodgkin's lymphoma
T16	Disorder 716 719	NHL
N14 	Reference T16 UMLS:C0024305	NHL
T18	Pharmacological_substance 840 852	Methotrexate
N1003 	Reference T18 MeSH:D008727	Methotrexate
T19	Pharmacological_substance 854 857	MTX
N1004 	Reference T19 MeSH:D008727	MTX
T20	Disorder 935 946	pelvic pain
N15 	Reference T20 UMLS:C0030794	pelvic pain
T22	Subject 51 58	patient
T25	Disorder 348 390	nodal and extranodal lymphoid malignancies
T26	Subject 285 293	patients
T28	Subject 626 649	17-year old JRA patient
T29	Disorder 802 805	JRA
N16 	Reference T29 UMLS:C3495559	JRA
N17 	Reference T29 UMLS:C3714757	JRA
T30	Disorder 1070 1089	lymphoid malignancy
N18 	Reference T30 UMLS:C0024299	lymphoid malignancy
N19 	Reference T30 UMLS:C0024299	lymphoid malignancy
T31	Disorder 1114 1117	JRA
N20 	Reference T31 UMLS:C3495559	JRA
N21 	Reference T31 UMLS:C3714757	JRA
T32	Subject 1118 1126	patients
T33	Pharmacological_substance 998 1020	cytotoxic chemotherapy
T39	Subject 491 499	patients
T40	Disorder 1096 1110	ovarian masses
N22 	Reference T40 UMLS:C0240611	ovarian masses
T42	Disorder 909 922	adnexial mass
T17	Coreferring_mention 948 959	The patient
